367 related articles for article (PubMed ID: 16157537)
41. Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.
Pellegrino D; Bonab AA; Dragotakes SC; Pitman JT; Mariani G; Carter EA
J Nucl Med; 2005 Sep; 46(9):1522-30. PubMed ID: 16157536
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.
Cheng C; Nakamura A; Minamimoto R; Shinoda K; Tateishi U; Goto A; Kadowaki T; Terauchi Y; Inoue T
Ann Nucl Med; 2011 Dec; 25(10):755-61. PubMed ID: 21818569
[TBL] [Abstract][Full Text] [Related]
43. Quantification of liver glucose metabolism by positron emission tomography: validation study in pigs.
Iozzo P; Jarvisalo MJ; Kiss J; Borra R; Naum GA; Viljanen A; Viljanen T; Gastaldelli A; Buzzigoli E; Guiducci L; Barsotti E; Savunen T; Knuuti J; Haaparanta-Solin M; Ferrannini E; Nuutila P
Gastroenterology; 2007 Feb; 132(2):531-42. PubMed ID: 17258736
[TBL] [Abstract][Full Text] [Related]
44. Biodistribution and planar gamma camera imaging of (123)I- and (131)I-labeled F(ab')(2) and Fab fragments of monoclonal antibody 14C5 in nude mice bearing an A549 lung tumor.
Burvenich IJ; Schoonooghe S; Blanckaert P; Bacher K; Vervoort L; Coene E; Mertens N; De Vos F; Slegers G
Nucl Med Biol; 2007 Apr; 34(3):257-65. PubMed ID: 17383575
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
46. Establishment of in vivo brain imaging method in conscious mice.
Mizuma H; Shukuri M; Hayashi T; Watanabe Y; Onoe H
J Nucl Med; 2010 Jul; 51(7):1068-75. PubMed ID: 20554730
[TBL] [Abstract][Full Text] [Related]
47. Effects of antifolate drugs on the cellular uptake of radiofolates in vitro and in vivo.
Müller C; Brühlmeier M; Schubiger PA; Schibli R
J Nucl Med; 2006 Dec; 47(12):2057-64. PubMed ID: 17138750
[TBL] [Abstract][Full Text] [Related]
48. Targeting post-infarct inflammation by PET imaging: comparison of (68)Ga-citrate and (68)Ga-DOTATATE with (18)F-FDG in a mouse model.
Thackeray JT; Bankstahl JP; Wang Y; Korf-Klingebiel M; Walte A; Wittneben A; Wollert KC; Bengel FM
Eur J Nucl Med Mol Imaging; 2015 Feb; 42(2):317-27. PubMed ID: 25112398
[TBL] [Abstract][Full Text] [Related]
49. Effects of administration route, dietary condition, and blood glucose level on kinetics and uptake of 18F-FDG in mice.
Wong KP; Sha W; Zhang X; Huang SC
J Nucl Med; 2011 May; 52(5):800-7. PubMed ID: 21498533
[TBL] [Abstract][Full Text] [Related]
50. Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
van Eerd JE; Laverman P; Oyen WJ; Harris TD; Edwards DS; Ellars CE; Corstens FH; Boerman OC
J Nucl Med; 2004 Jan; 45(1):89-93. PubMed ID: 14734679
[TBL] [Abstract][Full Text] [Related]
51. Assessment of PET tracer uptake in hormone-independent and hormone-dependent xenograft prostate cancer mouse models.
Kukuk D; Reischl G; Raguin O; Wiehr S; Judenhofer MS; Calaminus C; Honndorf VS; Quintanilla-Martinez L; Schönberger T; Duchamp O; Machulla HJ; Pichler BJ
J Nucl Med; 2011 Oct; 52(10):1654-63. PubMed ID: 21859811
[TBL] [Abstract][Full Text] [Related]
52. Detection of melanoma metastases with PET-Comparison of
Wang Y; Li M; Zhang Y; Zhang F; Liu C; Song Y; Zhang Y; Lan X
Nucl Med Biol; 2017 Jul; 50():33-38. PubMed ID: 28433794
[TBL] [Abstract][Full Text] [Related]
53. Biodistribution, pharmacokinetics and PET imaging of [(18)F]FMISO, [(18)F]FDG and [(18)F]FAc in a sarcoma- and inflammation-bearing mouse model.
Liu RS; Chou TK; Chang CH; Wu CY; Chang CW; Chang TJ; Wang SJ; Lin WJ; Wang HE
Nucl Med Biol; 2009 Apr; 36(3):305-12. PubMed ID: 19324276
[TBL] [Abstract][Full Text] [Related]
54. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
55. Whole-body tumor imaging using PET and 2-18F-fluoro-L-tyrosine: preliminary evaluation and comparison with 18F-FDG.
Hustinx R; Lemaire C; Jerusalem G; Moreau P; Cataldo D; Duysinx B; Aerts J; Fassotte MF; Foidart J; Luxen A
J Nucl Med; 2003 Apr; 44(4):533-9. PubMed ID: 12679396
[TBL] [Abstract][Full Text] [Related]
56. Analysis of the regional uptake of radiolabeled deoxyglucose analogs in human tumor xenografts.
Dearling JL; Flynn AA; Sutcliffe-Goulden J; Petrie IA; Boden R; Green AJ; Boxer GM; Begent RH; Pedley RB
J Nucl Med; 2004 Jan; 45(1):101-7. PubMed ID: 14734681
[TBL] [Abstract][Full Text] [Related]
57. Changes in 18F-FDG uptake within minutes after chemotherapy in a rabbit VX2 tumor model.
Song SL; Liu JJ; Huang G; Wang ZH; Song YY; Sun XG; Chen T
J Nucl Med; 2008 Feb; 49(2):303-9. PubMed ID: 18199614
[TBL] [Abstract][Full Text] [Related]
58. Comparative evaluation of FET and FDG for differentiating lung carcinoma from inflammation in mice.
Chang CH; Wang HE; Wu SY; Fan KH; Tsai TH; Lee TW; Chang SR; Liu RS; Chen CF; Chen CH; Fu YK
Anticancer Res; 2006; 26(2A):917-25. PubMed ID: 16619487
[TBL] [Abstract][Full Text] [Related]
59. Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan.
Zhao Y; Zhao S; Kuge Y; Tamaki N
J Nucl Med; 2013 Aug; 54(8):1384-8. PubMed ID: 23833272
[TBL] [Abstract][Full Text] [Related]
60. Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with
Chan SR; Salem K; Jeffery J; Powers GL; Yan Y; Shoghi KI; Mahajan AM; Fowler AM
J Nucl Med; 2018 May; 59(5):833-838. PubMed ID: 29217733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
